Sleep aid breakthrough? nicotinamide riboside put to the test
NCT ID NCT07284225
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a single dose of nicotinamide riboside (NR), a form of vitamin B3, can improve sleep in healthy adults who have mild sleep troubles. Twenty participants will have their sleep measured overnight using advanced monitoring, after taking either NR or a placebo. The goal is to see if NR affects total sleep time and sleep quality.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nicotinamide Riboside (NR)
What this could lead to
If it works, this could point toward a natural supplement that improves sleep quality in people with mild sleep difficulties.
What could go wrong
This is a very small, early-stage study in healthy volunteers, so results may not apply to the general public or those with sleep disorders. The effect, if any, may be minimal or not clinically meaningful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••